Welcome
Support Centre
02 September 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A prospective, randomised, controlled trial to evaluate the efficacy and safety of endoscopic choroid plexus coagulation with third ventriculostomy in the treatment of idiopathic normal pressure hydrocephalus
Source of recordUK Trials
ISRCTNISRCTN29863839
Date ISRCTN assigned17/10/2002
Local reference number(s)N/A
Public titleA prospective, randomised, controlled trial to evaluate the efficacy and safety of endoscopic choroid plexus coagulation with third ventriculostomy in the treatment of idiopathic normal pressure hydrocephalus
Scientific title
AcronymN/A
Disease/condition/study domainNormal pressure hydrocephalus
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewEthics information not required at time of registration.
Countries of trialUnited Kingdom
Participants - inclusion criteria1. A clinical diagnosis of Normal Pressure Hydrocephalus (NPH) by the following criteria:
a. Evidence of significant gait disturbance in the absence of other causative factors
b. Evidence of some cognitive impairment on formal neuropsychological testing (Mattis dementia rating scale and Folstein mini-mental state examination) and/or urinary incontinence or evidence of neurogenic urinary disturbance (frequency or urgency)
c. Lumbar Opening Pressure less than 20 mmHg on supine lumbar puncture
2. Symptom duration of more than six months
3. Evidence of disease progression since onset of symptoms
4. Radiological evidence of hydrocephalus, Evans ratio more than 0.3 on Computed Tomography (CT) scan of head
5. Patients must be fit enough to undergo operative surgical treatment, as defined by an American Society of Anesthesiologists (ASA) score of one, two or three
6. Written informed consent to participation in the study obtained from the patient, or next of kin if the patient is unable (due to cognitive impairment) to give informed consent
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/10/2002
Anticipated end date01/10/2003
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsTreatment group:
Endoscopic third ventriculostomy and choroid plexus coagulation.

Control group:
Programmable (Codman Medos valve) ventriculoperitoneal shunt.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingThe Frenchay Hydrocephalus Research Fund
Sponsor nameThe Frenchay Hydrocephalus Research Fund
Sponsor detailsFrenchay Hospital
Frenchay Park Road
Bristol
United Kingdom
BS16 1LE
Sponsor telephone+44 (0)117 970 1212
Sponsor websitehttp://www.northbristol.nhs.uk/hospitals/Frenchay.asp
Contact nameDr Ian K Pople
Contact detailsDepartment of Neurosurgery
Frenchay Hospital
Frenchay Park Road
Bristol
United Kingdom
BS16 1LE
Contact telephone+44 (0)117 975 3960
Contact fax+44 (0)117 970 1161
Contact emailikpople@hotmail.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN29863839
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central